Some researchers suspect that reducing GLP-1 medication dosage through a slow, sustained taper (instead of rapidly decreasing dosage over a short period of time, or stopping them suddenly altogether), could help some patients prevent rebound weight gain, but well need more data to confirm this with any confidence or say why it might be the case
Over time, this may contribute to the depletion of glutathione stores as the body works harder to neutralise free radicals and environmental toxins
The findings provide direct evidence that variation in the genes targeted by GLP-1 medications contribute to why people respond differently to GLP-1 therapies
Cody said that those under the program can access one of three medications, Foundayo, Wegovy or Zepbound, for $50 a month compared to retail prices that can run from $300 to $900 a month
The typical dosage ranges from 200 to 300 micrograms per injection, administered subcutaneously using an insulin syringe